Natural health product · NPN 80090744
affron
Yes: licensed in Canada
The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.
Licence status Active; licensed February 20, 2019; licence last revised August 29, 2022.
- Natural Product Number (NPN)
- 80090744
- Licence holder
- Barentz Canada ULC
- Dosage form
- Tablet
- Route
- Oral
- Licensing route
- Non-Traditional
- First licensed
- February 20, 2019
- Licence last revised
- August 29, 2022
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| Crocus sativus | 14 milligrams | Stigma; 3.48 % Crocin; 3.0:1.0 Dry; equivalent to 42.0 milligrams dried herb |
| Crocus sativus | — | Stigma; 0.03 % 2,6,6-Trimethylcyclohexa-1,3-diene-1-carbaldehyde |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- Helps to support mood balance. Helps to support mood balance in adolescents and youths 12 years and over. affron Helps to relieve restlessness and/or nervousness (calmative). Supports positive effects on symptoms of perceived stress such as, fatigue, weariness, and irritability. Helps to reduce the symptoms of perceived stress, such as fatigue, weariness, and irritability. Helps to improve restorative sleep in individuals experiencing sleeplessness. Helps improve sleep quality in individuals experiencing sleeplessness. Helps improve sleep quality in individuals experiencing sleeplessness. Helps to support/maintain (healthy) mood balance. Clinically proven to support/maintain (healthy) mood balance. Affron is clinically shown to relieve restlessness and/or nervousness (calmative). Clinically shown to support positive effects on symptoms of perceived stress such as, fatigue, weariness, and irritability. Clinically shown to reduce the symptoms of perceived stress, such as fatigue, weariness, and irritability. Clinically shown to improve restorative sleep in individuals experiencing sleeplessness. Supports the management of symptoms associated with perimenopause. Helps improves sleep quality. Clinically proven to help improve sleep quality. Clinically proven to help improve sleep quality in 4 weeks. Clinically proven to improve sleep quality in individuals experiencing sleeplessness. May help to support healthy mood balance during perimenopause. Helps to support healthy mood balance during perimenopause. Clinically shown to help relieve symptoms associated with perimenopause. Helps to support mood balance after awakening. Helps to support healthy mood balance after awakening. Nighttime sleep aid.
Non-medicinal ingredients
Microcrystalline cellulose; Calcium hydrogen phosphate